Quick Overview
- SNOW shares declined 11.8% Thursday, closing near $132 after opening at $149.99
- Volume surged to 152% above typical levels, exceeding 15 million shares traded
- Securities-fraud class-action suit carries a lead plaintiff deadline of April 27, 2026, intensifying legal scrutiny
- Reports emerged of customer data compromised through third-party integration vulnerabilities
- Software sector faced widespread selling pressure driven by concerns about AI agents replacing conventional SaaS platforms
Thursday proved challenging for Snowflake (SNOW), with shares tumbling 11.8% from $149.99 down to approximately $132. The session saw exceptional activity, with volume exceeding normal levels by more than 150%. Such elevated trading typically signals significant catalysts at work — and multiple factors converged simultaneously.
Multiple headwinds created compounding pressure on the stock.
Legal firms have issued numerous investor notifications related to a securities-fraud class-action lawsuit spanning June 2023 through February 2024. With the lead plaintiff deadline set for April 27, 2026, these announcements have resurfaced, keeping regulatory uncertainties front and center for shareholders.
Additionally, new disclosures revealed customer data theft incidents. While the compromises originated from a third-party integration partner rather than Snowflake’s primary infrastructure, the company acknowledged detecting “unusual activity.” Such language raises red flags for market participants evaluating security risks.
Widespread Software Sector Turbulence
Thursday’s selloff extended across the software landscape, with SNOW representing just one casualty. Market observers attribute the decline to mounting anxiety that AI agents may diminish or eliminate demand for conventional enterprise software solutions. Cloudflare (NET) surrendered roughly 12%, ServiceNow (NOW) lost approximately 7%, and Snowflake experienced similar downward momentum.
The underlying thesis is clear: AI-powered agents capable of automating tasks currently performed by SaaS platforms could erode their market value. This valuation reassessment has been developing over several months, with Thursday appearing to mark a significant acceleration.
Recent insider transactions have contributed additional uncertainty. Corporate insiders offloaded approximately $108 million in shares during the past quarter. Director Michael Speiser reduced his holdings by more than 62% in early March. EVP Christian Kleinerman divested 10,000 units in February. These represent substantial position changes.
Analyst Community Maintains Optimistic Outlook
The recent decline hasn’t prompted widespread downgrades from Wall Street. The consensus rating holds at “Moderate Buy” with average price targets clustering around $249.62 — representing substantial upside from current trading levels.
Optimistic analysts emphasize Cortex AI, Snowflake’s integrated AI platform, alongside expanding developer adoption. Healthcare technology firm Penguin AI exemplifies this trend, constructing workflow applications directly within the Snowflake AI Data Cloud ecosystem.
The company recently introduced Iceberg V3 compatibility, enhancing data portability capabilities and potentially addressing enterprise customer concerns regarding platform dependency.
Top-line performance remains robust. Snowflake’s latest quarterly results showed $1.28 billion in revenue, representing 30.1% year-over-year expansion and exceeding analyst projections. Earnings per share reached $0.32, surpassing the $0.27 consensus estimate.
Profitability metrics present challenges. The company continues reporting a negative net margin of 28.43% alongside a negative return on equity of 50.61%. Year-to-date performance shows a decline exceeding 31%, with current pricing substantially below both the 50-day moving average of $169.90 and the 200-day moving average of $213.12.
Rosenblatt Securities maintained its Buy recommendation with a $275 price objective in late February. DA Davidson preserved its Buy stance while adjusting its target downward from $300 to $250. TD Cowen similarly revised expectations from $270 to $255 while retaining positive recommendations.
